ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` W Table_1 r q Variable- Functional iron
deficiency (n = 65)! Iron overload
(n = 111) p Females
19 (29.3%)
32 (28.8%) 0.9548 Males
46 (70.7%)
79 (71.2%) Race/ethnlclty 0.3253 White
46 (63.0%)
70 (63.6%) Black
10 (13.6%) 30 (272%) Brown 6 (8.2%) 8 (72%) Yellow 3 (4.1%) 3 (2.7%) Age (years) (mean) (95%CI) 55.0 (51.0 - 59.1) 54.5 (21.6 - 574) 0.8230" Time on HD (months) (median) (IQR) 48.0 (12.0 - 75.0) 48.0 (24.0 - 81.0) 0.3992 KtV (median) (IQR) 1.370 (1.210-1.480) 1.390 (1.260-1.530) 0.4788! Creatinine (mean) (mg/dL) (95%CI) 8.83 (8.04-9.62) 9.30 (8.71-9.90) 0.3404 Albumin (median) (g/dL) (IQR) 4.05 (3.80-4.30) 4.20 (4.10-4.50) 0.0020§ BMI (median) (IQR) 23.1 (21.0 - 26.1) 25.1 (22.0 - 29.2) 0.0075§' Waist circumference (median) (cm) (IQR) 89.25 (82.00-99.75) 99.00 (8725-108.00) 0.0036§/ Mid-upper arm circumference (median) (cm) (IQR) 26.00 (24.00-29.00) 28.00 (26.00-30.50) 0.0076 Diabetes
65 (89.0%)
97 (88.2%) 0.8583 Hypertension
58 (89.2%) 97 (874%) 0.9020 Smoking 8 (12.3%)
12 (10.8%) 0.9554 Alcohol drinking 10 (9.2%)
18 (16.2%) 0.8843 Previous PTX
13 (20.0%)
15 (23.1%) 0.3565# Use of calcium carbonate or acetate
37 (56.9%) 6 (62.2%) 0.5990 Use of sevelamer
27 (41.5%)
61 (55.0%) 0.1183 Use of calcitriol
23 (35.4%)
38 (34.2%) 0.8770 Use of ACEi/ARB
38 (58.5%)
55 (49.5%) 0.3238 Use of statins
21 (32.3%)
25 (22.5%) 0.2120$ Serum calcium (mg/dL) (median) (IQR) 8.12 (783-8.41) 8.42 (8.21-8.64) 0.0963' Serum phosphorus (median) (mg/dL) (IQR) 5.70 (4.30-6.60) 5.60 (4.70-720) 0.6097) Alkaline phosphatase (median) (U/L) (IQR) 126.0 (85.0-208.0) 161.0 (101.0-215.5) 0.1604 PTH (median) (pg/mL) (IQR) 326.8 (145.30-7070) 462.7 (165.00-941.35) 0.2561
d MbP?_ % * + &P &F